The government is planning to bring painkiller Tapentadol and epilepsy drug Pregabalin under strict control and monitoring to ...

About 4 million American adults have the chronic condition. Treatment may include a combination of painkillers, cognitive ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...

Compared to the control drugs tested (gabapentin and MK-801), AV-101 has similar robust anti ... Further preclinical research conducted by Dr. Yaksh comparing AV-101 to pregabalin in the Chung ...

CLEVELAND, OH (CLEVELAND CLINIC) - Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, which was just approved by the FDA, could ...

Vertex’s pill, called Journavx, received US Food and Drug Administration clearance to treat moderate to severe acute pain, a statement said on Thursday. The wholesale acquisition cost for the ...

A new kind of pain medication has been approved for sale by the Food and Drug Administration. It is being touted as an alternative to opioids. It works differently, and it is not addictive. NPR's Yuki ...

For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, the first new class of pain medication in more than two decades. Developed by Vertex Pharmaceuticals, the drug-known generically as ...

The FDA's sign-off on the medication comes as the agency says it is prioritizing supporting the development of non-opioid pain treatment. Suzetrigine is the first non-opioid analgesic – or ...